7.68
1.54%
-0.12
Dopo l'orario di chiusura:
7.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Optimizerx Corp Borsa (OPRX) Ultime notizie
OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat
OptimizeRx expands pharma client engagement to $10M - Investing.com
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - The Tech Outlook
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a - The Bakersfield Californian
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value - StockTitan
OptimizeRx Launches Novel Brand Eligibility Technology - Martechcube
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - ForexTV.com
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences - StockTitan
Down -12.46% in 4 Weeks, Here's Why OptimizeRx (OPRX) Looks Ripe for a Turnaround - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $14.00 - Defense World
Vanguard Group Inc. Raises Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx (NASDAQ:OPRX) PT Lowered to $11.00 - Defense World
A Closer Look at 5 Analyst Recommendations For OptimizeRx - Benzinga
Earnings Release: Here's Why Analysts Cut Their OptimizeRx Corporation (NASDAQ:OPRX) Price Target To US$15.79 - Yahoo Finance
OptimizeRx Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance UK
Contrasting OptimizeRx (NASDAQ:OPRX) and Joint Stock Company Kaspi.kz (NASDAQ:KSPI) - Defense World
Earnings call: OptimizeRx reports solid growth, misses revenue target - Investing.com
OptimizeRx Corporation (NASDAQ:OPRX) Q2 2024 Earnings Call Transcript - Insider Monkey
OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates - MSN
OptimizeRx Corp. (OPRX) Tops Q2 Earnings Estimates - Yahoo Canada Finance
OptimizeRx Reports Second Quarter 2024 Financial Results - StockTitan
Institutional investors may adopt severe steps after OptimizeRx Corporation's (NASDAQ:OPRX) latest 24% drop adds to a year losses - Yahoo Finance
Smith Micro Software, Inc. (SMSI) Reports Q2 Loss, Misses Revenue Estimates - Zacks Investment Research
OptimizeRx (OPRX) to Release Earnings on Thursday - MarketBeat
OptimizeRx Corp. (OPRX) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Thursday - Defense World
Acadian Asset Management LLC Cuts Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Analysts Issue Forecasts for OptimizeRx Co.'s Q3 2024 Earnings (NASDAQ:OPRX) - MarketBeat
Q3 2024 Earnings Estimate for OptimizeRx Co. (NASDAQ:OPRX) Issued By B. Riley - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Forecasted to Earn Q2 2024 Earnings of ($0.26) Per Share - Defense World
OptimizeRx Co. (NASDAQ:OPRX) to Post Q2 2024 Earnings of ($0.26) Per Share, B. Riley Forecasts - MarketBeat
OptimizeRx (NASDAQ:OPRX) Coverage Initiated by Analysts at B. Riley - MarketBeat
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - ForexTV.com
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - StockTitan
OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET - EIN News
OptimizeRx Co. (NASDAQ:OPRX) Shares Acquired by BNP Paribas Financial Markets - Defense World
OptimizeRx adapts to US privacy laws for pharma marketing - Investing.com
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing ... - NRToday.com
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation - StockTitan
OptimizeRx adapts to US privacy laws for pharma marketing - Investing.com India
RPC (NYSE:RES) Shares Down 4% - Defense World
OptimizeRx Co. (NASDAQ:OPRX) Receives $16.00 Average Target Price from Analysts - MarketBeat
Mirae Asset Global Investments Co. Ltd. Sells 3,278 Shares of MaxLinear, Inc. (NYSE:MXL) - Defense World
Mirae Asset Global Investments Co. Ltd. Reduces Position in Teekay Tankers Ltd. (NYSE:TNK) - Defense World
Mirae Asset Global Investments Co. Ltd. Invests $542,000 in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
Mirae Asset Global Investments Co. Ltd. Sells 2,581 Shares of The Carlyle Group Inc. (NASDAQ:CG) - Defense World
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients - ForexTV.com
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients - StockTitan
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients – IT Business Net - IT Business Net
Essex Investment Management Co. LLC Takes $1.05 Million Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
VSee Health (NASDAQ:VSEE) Stock Quotes, Forecast and News Summary - Benzinga
Currys plc (LON:CURY) Insider Steve Johnson Acquires 40,000 Shares - Defense World
OptimizeRx (NASDAQ:OPRX) shareholders have endured a 83% loss from investing in the stock three years ago - Yahoo Finance
OptimizeRx Corp. (OPRX) Tops Q3 Earnings Estimates - Yahoo New Zealand News
Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know - Markets Insider
Critical Insights From OptimizeRx Analyst Ratings: What You Need To KnowOptimizeRx (NASDAQ:OPRX) - Benzinga
OptimizeRx (NASDAQ:OPRX) Earns "Market Outperform" Rating from JMP Securities - MarketBeat
Should You Buy OptimizeRx (OPRX) Ahead of Earnings? - Yahoo Movies Canada
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients ... - WDRB
New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations - GlobeNewswire Inc.
Check Out OptimizeRx Corp (OPRX)'s Trade Data Rather Than the Analysts' Views – Sete News - SETE News
OptimizeRx Co. (NASDAQ:OPRX) Shares Sold by Quarry LP - Defense World
G2 Investment Partners Management LLC Buys 96,646 Shares of OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp. (OPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo New Zealand News
First Light Asset Management LLC Has $24.72 Million Stake in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Avenir Corp Has $1.26 Million Stock Holdings in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):